retatrutide synthesis 💠 (Reta) is a synthetic peptide-based drug composed of 39 amino acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases Retatrutide - More Biotechnology

Talk to a Pharmacologist Question we didn't answer

International Journal of Obesity (London), 2012;36(6):843-854

If you are curious about how GLP-1 drops work in general, the concept relies on bypassing the digestive system to improve bioavailability, though the evidence for this approach with supplement ingredients remains limited

Adults on GLP-1 medications need about 1.2-1.6 grams of protein per kilogram of body weight

10, 11 However, it will be necessary to confirm these results in a larger phase 3 program in obese adults, both in terms of efficacy and (particularly) safety and tolerability

The energy dip that sometimes accompanies the first 24 hours post-injection happens during the day when you can manage it with light activity, caffeine if tolerated, and strategic eating